[Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
D000017:ABO Blood-Group System / Q000032:analysis*; D000906:Antibodies / Q000032:analysis; D001663:Bilirubin / Q000097:blood; D001787:Blood Group Incompatibility / Q000175:diagnosis*; D004899:Erythroblastosis, Fetal / Q000175:diagnosis / Q000517:prevention & control; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D006460:Hemolysin Proteins / Q000032:analysis; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007518:Isoantibodies / Q000032:analysis; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011295:Prenatal Care; D012189:Retrospective Studies
D000017:ABO Blood-Group System; D000906:Antibodies; D006460:Hemolysin Proteins; D007518:Isoantibodies; D001663:Bilirubin
Zur Früherfassung der ABO-Unverträglichkeit. Katamnestische Erhebungen bei 141 Schwangerschaften mit Verdacht oder klinischem Nachweis einer ABO-Unverträglichkeit.